Liz Claydon

Liz has recently transitioned into the lead partner role for a major pharmaceutical. She is one of the most experienced Deal Advisory partners, and has led the global M&A relationship with the major pharmaceutical for the past 10 years. During this time Liz and her team have advised on some of the largest and most complex deals undertaken by the major pharmaceutical including the 1.4bn sale of their two drinks brands as part of an OTC non-core brand divestment programme in 2010. Liz’s background reflects complex advisory on the some of the largest cross boarder deals of recent time and she has led domestic transactions. Liz has been involved with numerous Pharma bolt on acquisitions and a number of integration projects including the Novartis JV.